Recro Pharma Inc (REPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REPH | ACHV | SAVA | ||
| Company | Recro Pharma Inc | Achieve Life Sciences Inc | Cassava Sciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.07 | 3.72 | 2.34 | ||
| High | 2.14 | 3.84 | 2.68 | ||
| Low | 2.00 | 3.66 | 2.31 | ||
| Last | 2.09 | 3.78 | 2.41 | ||
| Change | -0.01 | +0.09 | +0.06 | ||
| % Change | -0.48% | +2.44% | +2.55% | ||
| Volume | 141,800 | 192,300 | 4,202,400 | ||
| 20-Day Average Volume | 122,300 | 147,115 | 12,302,470 | ||
| Previous Close | 2.10 | 3.69 | 2.35 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.84 | 4.27 | 3.04 | ||
| 20-Day Raw Stochastic | 85.07% | 17.06% | 6.52% | ||
| 20-Day Relative Strength | 65.13% | 34.44% | 26.35% | ||
| Weighted Alpha | -25.90 | -17.75 | -70.63 | ||
| Today's Opinion | 40% Buy | 100% Sell | 88% Sell | ||
| Previous Opinion | 40% Buy | 96% Sell | 88% Sell | ||
| Last Month's Opinion | 56% Sell | 72% Sell | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.18% since 03/14/22 | -8.47% since 12/16/24 | -9.40% since 12/16/24 | ||
| Low | 1.94 on 03/15/22 | 3.60 on 12/20/24 | 2.23 on 12/20/24 | ||
| High | 2.19 on 03/18/22 | 4.20 on 12/18/24 | 2.70 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | +30.62% since 02/18/22 | -11.89% since 11/22/24 | -90.90% since 11/22/24 | ||
| Low | 1.52 on 02/24/22 | 3.60 on 12/20/24 | 2.23 on 12/20/24 | ||
| High | 2.19 on 03/18/22 | 4.66 on 12/10/24 | 4.99 on 11/25/24 | ||
| 3-Month | |||||
| %Chg | +35.71% since 12/21/21 | -13.70% since 09/23/24 | -91.08% since 09/23/24 | ||
| Low | 1.42 on 01/31/22 | 3.60 on 12/20/24 | 2.23 on 12/20/24 | ||
| High | 2.19 on 03/18/22 | 5.31 on 11/06/24 | 33.98 on 11/21/24 | ||
| 6-Month | |||||
| %Chg | +1.95% since 09/21/21 | -23.94% since 06/21/24 | -87.96% since 06/21/24 | ||
| Low | 1.38 on 12/06/21 | 3.60 on 12/20/24 | 2.23 on 12/20/24 | ||
| High | 2.20 on 09/23/21 | 5.31 on 11/06/24 | 42.20 on 08/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 117,926 | 129,994 | 115,945 | ||
| Shares Outstanding, K | 56,424 | 34,390 | 48,110 | ||
| Annual Sales | 75,360,000 | 0 | 0 | ||
| Annual Net Income | -11,370,000 | -29,820,000 | -97,220,000 | ||
| Last Quarter Sales | 22,300,000 | 0 | 0 | ||
| Last Quarter Net Income | -2,360,000 | -12,510,000 | -27,940,000 | ||
| 60-Month Beta | 1.08 | 1.58 | -0.85 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.36 on 11/07/24 | -0.58 on 11/07/24 | ||
| Latest Earnings Date | 05/05/22 | 11/07/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | 0.750 on 12/13/12 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||